The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, member-supported business development association for the global pharmaceutical manufacturing industry. DCAT is committed to providing programs, events, and services that help its members expand their network of customers, suppliers,

and colleagues in the industry. For more information, visit DCAT’s website at www.dcat.org

The essential resource on pharmaceutical manufacturing, sourcing/procurement, and supply management.

DCAT Value Chain Insights is the industry’s essential information resource from the Drug, Chemical & Associated Technologies Association (DCAT) on pharmaceutical development, manufacturing, and the supply chain.

DCAT Value Chain Insights is delivered electronically each Wednesday and housed at www.DCATvci.org. It is tailored for senior to mid-level executives of pharma/biopharm companies, contract manufacturers, and suppliers engaged in the entire value chain from raw materials to intermediates to drug substances to drug products to packaging and logistics.

DCAT Value Chain Insights covers drug substances (small molecules and biologics) and drug products (solid dosage, parenterals, and specialty dosage forms) as well as packaging, logistics, and related supply-chain issues.

Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace:

About DCAT Value Chain Insights Patricia Van Arnum, Editorial Director, DCAT Contact: pvanarnum@dcat.org Main Line: 609.208.1888

Patricia Van Arnum, Editorial Director, DCAT, has more than 20 years of experience as a business and science editor and journalist, which includes covering the pharmaceutical, biopharmaceutical, and fine-chemicals industries. Prior to joining DCAT, Ms. Van Arnum was Executive Editor of Pharmaceutical Technology from 2006 to 2014 and Executive Editor of ICIS Chemical Business and Chemical Market Reporter (CMR) from 1995–2005.

Special Preview Coverage(Countdown to DCAT Week ’18)

in the March 7 and March 15, 2018 issues.

Special Post DCAT Week Coverage

in the April 4, 2018 issue

● Market Watch: Analysis of the performance and projections for key market sectors.

● Industry Radar: In-depth analysis of key segments of the pharmaceuticalmanufacturing value chain.

● Executive Insights: The Newsmakers provides analysis of strategies of leadingexecutives from the pharmaceutical companies making the news, and DCAT ValueChain Insights Top Ten offers highlights of significant pharma industry trends.

● Best Practices: Peer insight on the organizational, operational, and managementfor sourcing, procurement, and supply management.

● Major Industry News, Pharma News and Supplier News: Delivered in every issue of DCAT Value Chain Insights, aroundup of the top news from pharmaceutical and biopharmaceutical companies, contract manufacturers, and suppliers.Plus the key regulatory and compendial developments impacting pharmaceutical manufacturing and the supply chain.

● Plus Top Industry News: To help ensure DCAT members never miss the most important stories impacting the globalpharmaceutical manufacturing value chain, DCAT delivers each Friday, the week's Top Industry News, as selected byDCAT Editorial Director Patricia Van ArnumSee the DCAT Value Chain Insights 2018 Editorial Calendar for full details.

One Union Street, Suite 208, Robbinsville, NJ 08691 · Toll Free: +1.800.640.DCAT · Local: 609.208.1888 · Fax: 609.208.0599

10 17 24 31

JANUARY

7 14 21 28

FEBRUARY

MARCH

7 14

4 11 18 25

APRIL

MAY

2 9 16 23 30

Market Watch: Pharma Industry Outlook

JUNE

6 13 20

Industry Radar: The Year Ahead inPharma Outsourcing

Executive Insights:Top 10 Pharma Watch List for 2018

Best Practices: Big Data

Market Watch:Small-MoleculeDrugs

Industry Radar:Parenteral Drugs

Executive Insights:The Newsmakers

Best Practices:Supplier RelationshipManagement

Special Report:Countdown to DCAT Week

Special Report:Countdown to DCAT Week

Special Report:DCAT Week Review

Industry Radar:Biologics

Executive Insights: Top 10 Blockbusters of the Future

Market Watch:U.S. Pharma Industry Outlook

Industry Radar:Fine Chemicals

Special Report:DCAT Sharp Sourcing Preview

Executive Insights:The Newsmakers

Best Practices:Supply-Chain Management

Market Watch:Generic Drugs

Industry Radar:Outsourcing Trends

Executive Insights:Mid-Year Review: Top 10 Deals of 2018

21 28

No Issue No Issue

Best Practices:Sourcing

27

No Issue

2018 Editorial Calendar

JULY

AUGUST

SEPTEMBER

OCTOBER

NOVEMBER

DECEMBER

4 11 18

1 8 15 22

5 12 19 26

No IssueIndustry Radar:Drug Delivery

Executive Insights:The Newsmakers

Market Watch:Emerging Pharma

Industry Radar:Biologics

Executive Insights: The Newsmakers

Best Practices:Supplier Relationship Management

Market Watch:Specialty Pharma

Industry Radar:High-Potency Manufacturing

Executive Insights:Top 10 Trends in Pharma Manufacturing

Best Practices:Data Integrity

3 17 24 31

7 14 28

5 12

Market Watch:Generic Drugs

Industry Radar:CDMO/CMOExpansions Update

Executive Insights:The Newsmakers

Best Practices:Supplier-Enabled Innovation

Market Watch:API Outlook

Industry Radar:Biosimilars

Best Practices:Sourcing in Emerging Markets

Market Watch:The Year in Review

Industry Radar:Top 10 Emerging Trends

19 26

No Issue No Issue

25Special Report:Sharp Sourcing Review

2018 Editorial Calendar